tirzepatide for mcas New research highlights the use of #GLP1 receptor agonists (like semaglutide & tirzepatide) in treating mast cell activation syndrome (MCAS). In this case series, patients reported: • Rapid symptom relief (fatigue, brain The GLP-1 Agonist Boom in

In the meantime, the availability of the two highest-dose Zepbound vials gives providers and patients another important treatment option."(Source: Eli Lilly & Co., June 2025) Ozempic captures close to 60% of the GLP-1 receptor agonist category, underscoring its lead among semaglutide-based therapies

L-carnitine treatment could not reverse the hypertriglyceridemia and hypercholesterolemia in the cachexic mice, and actually increased the serum levels of triglycerides and total cholesterol

101 Albiglutide Albiglutide was approved by the FDA in 2014

Eye Health: Regular intake can reduce the risk of macular degeneration, a leading cause of vision loss